| Product Name | MF | CAS | Details |
|---|
| 1-[(tert-Butoxy)carbonyl]-1H-indole-6-carboxylic acid | C14H15NO4 | 208772-42-3 | Details |
| 3-Ethoxy-4-(2-phenoxyethoxy)benzaldehyde | C17H18O4 | 299934-86-4 | Details |
| Piperidine-1-sulfonyl chloride | C5H10ClNO2S | 35856-62-3 | Details |
| FA-Phe-Phe-OH | C25H24N2O5 | 83661-95-4 | Details |
| 4-Amino-8-bromoquinoline-3-carbonitrile | C10H6BrN3 | 1247850-63-0 | Details |
| (S,R,S)-AHPC-C8-NH2 | C31H47N5O4S | 2341796-79-8 | Details |
| 2-Amino-3-hydroxyanthraquinone | C14H9NO3 | 117-77-1 | Details |
| LCH-7749944 | C20H22N4O2 | 796888-12-5 | Details |
| (6-Methoxy-1,3-benzodioxol-5-yl)amine hydrochloride | C8H10ClNO3 | 115132-95-1 | Details |
| m-dPEG?24-Amido-dPEG?24-TFP Ester | Details |
| 1-(3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-D-arabinofuranosyl)uracil | Details |
| 8-Bromo-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepin-1-one | C8H9BrN2O | 1379343-79-9 | Details |
| HB Blocking Peptide | Details |
| 3-Indolyl b-D-cellotrioside | Details |
| Hythiemoside B | C28H46O9 | 853267-90-0 | Details |
| 4-(3-Morpholinopropyl)-3-thiosemicarbazide | C8H18N4OS | 32813-48-2 | Details |
| 5-[3-(Dimethylamino)phenyl]-4H-1,2,4-triazol-3-amine | C10H13N5 | 910443-59-3 | Details |
| 2-{[(tert-butoxy)carbonyl]amino}-4,4,4-trifluorobutanoic acid | C9H14F3NO4 | 544479-61-0 | Details |
| 3,4,5,6-Tetrafluoro-N-methylphthalimide | C9H3F4NO2 | 33795-85-6 | Details |
| Polacrilin Potassium | Details |
| 2-Methylbenzenesulfonamide | C7H9NO2S | 88-19-7 | Details |
| GADD45B protein | Details |
| Spiro[chromene-2,3'-pyrrolidine] hydrochloride | C12H14ClNO | 1047656-01-8 | Details |
| HSP90AB1 antibody | Details |
| C14orf169 antibody | Details |
| N-(3-Aminophenyl)-N-methylacetamide | C9H12N2O | 61679-27-4 | Details |
| tert-Butyl N-[(tert-butoxy)carbonyl]-N-(4-oxobutyl)carbamate | C14H25NO5 | 177899-21-7 | Details |
| Pueroside A | C29H34O14 | 100692-52-2 | Details |
| Phenyl-beta-D-thioglucopyranoside | C12H16O5S | 2936-70-1 | Details |
| Glutaminase Inhibitor II, BPTES | C24H24N6O2S3 | 314045-39-1 | Details |
| 4-(2-Fluorophenyl)-1,3-Thiazol-2-Amine | C9H7FN2S | 145029-82-9 | Details |
| 2-(2,2-Dichloro-1-methylcyclopropyl)acetic acid | C6H8Cl2O2 | 5508-89-4 | Details |
| Polysorbate 80 | C24H44O6 | 9005-65-6 | Details |
| 3-(1H-1,2,3,4-Tetrazol-5-yl)morpholine hydrochloride | C5H10ClN5O | 1820705-11-0 | Details |
| (5S)-3,5-Dimethylimidazolidine-2,4-dione | C5H8N2O2 | 71921-89-6 | Details |
| PPM1G antibody | Details |
| H-VGEFSGANK-OH | Details |
| Isodesoxypodophyllotoxin | C22H22O7 | 17187-81-4 | Details |
| 5-Ethyl-3-(2-methoxyethyl)-6-methyl-2-sulfanyl-3H,4H-thieno[2,3-d]pyrimidin-4-one | C12H16N2O2S2 | 743452-33-7 | Details |
| ...CLEAR-OX | Details |
| N-1H-Benzimidazol-2-yl-3-(1H-pyrrol-1-yl)benzamide | C18H14N4O | 1190277-80-5 | Details |
| IRF2BP1 Blocking Peptide | Details |
| 2-Fluoro-4-(methylsulfonyl)benzaldehyde | C8H7FO3S | 1197193-11-5 | Details |
| GABARAPL2 antibody | Details |
| 3-Fluoro-5-methylpyridine-2-carboxylic acid | C7H6FNO2 | 1256807-03-0 | Details |
| C20ORF20 Blocking Peptide | Details |
| Activity-Dependent Neurotrophic Factor-14 | C58H103N17O17 | Details |
| 6-(2,2-Dimethyl-propionylamino)-nicotinic acid | C11H14N2O3 | 898561-66-5 | Details |
| IFN-Tau 2B protein (Bovine) | Details |
| 4-Methyl-1-thia-4,8-diazaspiro[4.5]decan-3-one hydrochloride | C8H15ClN2OS | 1432680-93-7 | Details |
| Transglutaminase Antibody | Details |
| 2-(Quinolin-8-yl)ethan-1-amine | C11H12N2 | 910381-50-9 | Details |
| 2-Amino-2-methyl-4-(methylsulfanyl)butanenitrile hydrochloride | C6H13ClN2S | 1803586-03-9 | Details |
| N-Cycloheptyl-N-ethylamine | C9H19N | 45806-60-8 | Details |
| 2-Hydroxy-[1,1'-biphenyl]-3-carboxylic acid | C13H10O3 | 304-06-3 | Details |
| 1-[(tert-Butoxy)carbonyl]-4-hydroxy-2-methylpyrrolidine-2-carboxylic acid | C11H19NO5 | 1432056-71-7 | Details |
| CRA 026440 | C23H24N4O4 | 847460-34-8 | Details |
| Methyl 2-amino-2-cyclohexylacetate hydrochloride | C9H18ClNO2 | 322392-74-5 | Details |
| D-Glucose (5-13C) | C6H12O6 | 120388-24-1 | Details |
| VCL Blocking Peptide | Details |
| 3-Bromo-5-hydroxybenzamide | C7H6BrNO2 | 1243362-78-8 | Details |
| 3-Bromo-4-(hydroxymethyl)thiophene | C5H5BrOS | 70260-05-8 | Details |
| 13-Epimanool | C20H34O | 1438-62-6 | Details |
| Methyl 3-amino-2-methyl-2-phenylpropanoate hydrochloride | C11H16ClNO2 | 1253955-52-0 | Details |
| Dimethyl-1H-1,2,3-triazole-5-sulfonyl chloride | C4H6ClN3O2S | 1780688-94-9 | Details |
| CD44 antibody (PE-CY7) | Details |
| 2-Chloro-5-[(cyclopropylmethoxy)methyl]pyridine | C10H12ClNO | 1019546-38-3 | Details |
| 5-[(4-Butylphenyl)sulfamoyl]-2,4-dichlorobenzoic acid | C17H17Cl2NO4S | 380193-99-7 | Details |
| PRN1371 | C26H30Cl2N6O4 | 1802929-43-6 | Details |
| 1-Amino-3-(2,2,2-trifluoroethyl)imidazolidin-2-one | C5H8F3N3O | 1715035-12-3 | Details |
| Candesartan-d5 | C24H19N6O3 | 1189650-58-5 | Details |
| 3-(4-phenylpiperazinyl)-2-(phenylsulfonyl)prop-2-enenitrile | C19H19N3O2S | 903195-59-5 | Details |
| (5-Phenylfuran-2-yl)methanamine | C11H11NO | 39170-18-8 | Details |
| 3-Amino-4-(piperidin-1-yl)benzamide hydrochloride | C12H18ClN3O | 1171863-21-0 | Details |
| SYT9 antibody | Details |
| rac Efavirenz-d4 | C14H9ClF3NO2 | 1246812-58-7 | Details |
| Procyanidin B-5 3,3'-di-o-gallate | C44H34O20 | 106533-60-2 | Details |
| N-Acetyl-2'-O-[(tert-butyl)dimethylsilyl]-5'-O-DMT-6'-O-methylguanosine-3'-CE phosphoramidite | C49H66N7O9PSi | 153248-58-9 | Details |
| 1-Deoxy-1-[(2,6-dimethoxy-5-nitro-4-pyrimidinyl)amino]-D-ribitol | C11H18N4O8 | 669088-28-2 | Details |
| 1-[2-(Propan-2-yl)phenyl]piperazine | C13H20N2 | 119695-82-8 | Details |
| (2,2-Difluoro-1-methyl-cyclopropyl)methanol | C5H8F2O | 128230-72-8 | Details |
| N-[4-(2-Chloroacetyl)phenyl]benzamide | C15H12ClNO2 | 853574-47-7 | Details |
| 5-Bromo-4-chloro-2-methoxypyrimidine | C5H4BrClN2O | 57054-93-0 | Details |
| 6-(3-Amino-2-hydroxypropoxy)-1,2,3,4-tetrahydroquinolin-2-one | C12H16N2O3 | 954580-47-3 | Details |
| H-YPSKPDNPGE-OH | Details |
| H-VDTVDPPYPR^-OH | Details |
| N2,N2-Dimethyl-N6-(1-oxododecyl)-L-lysine | C20H40N2O3 | 38079-57-1 | Details |
| KAP8.1 Blocking Peptide | Details |
| N-(3,4-Dichlorophenyl)-5-methyl-4,5-dihydro-1,3-thiazol-2-amine | C10H10Cl2N2S | 355156-82-0 | Details |
| (1S,4R)-methyl 4-aminocyclopent-2-enecarboxylate HCl | C7H12ClNO2 | 229613-83-6 | Details |
| 2-Bromo-6-chloro-4-(trifluoromethyl)benzoic acid | C8H3BrClF3O2 | 1956322-96-5 | Details |
| 27-Carboxy-7-keto cholesterol | C27H42O4 | 148988-30-1 | Details |
| 3-(3,4-Difluorophenyl)-2-methylpyrrolidine hydrochloride | C11H14ClF2N | 2248351-76-8 | Details |
| SLC30A1 Blocking Peptide | Details |
| Tet-20 | C78H141N31O14S | Details |
| 2,2-Difluoro-2-(5-methylthiophen-3-yl)acetic acid | C7H6F2O2S | 1462248-74-3 | Details |
| N-(2-Furyl)imino-2,3,4,6-tetra-O-pivaloyl-b-D-glucopyranoside | Details |
| TIFIA antibody | Details |
| (2R)-2-Methyl-3-phenylpropanoic acid | C10H12O2 | 14367-67-0 | Details |
| GPR150 antibody | Details |
| Product Total： Product Page： | ||||
| 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 | ||||